Corinne Betts
Postdoctoral Research Scientist
Corinne has an interest in metabolic disturbances prevalent in neuromuscular diseases, and whether we can ameliorate the phenotype with pharmacological or dietary intervention
Recent publications
-
Uniform sarcolemmal dystrophin expression is required to prevent extracellular microRNA release and improve dystrophic pathology.
Journal article
van Westering TLE. et al, (2020), J Cachexia Sarcopenia Muscle, 11, 578 - 593
-
A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.
Journal article
Yin H. et al, (2019), Hum Mol Genet, 28
-
Cell-Penetrating Peptide Conjugates of Steric Blocking Oligonucleotides as Therapeutics for Neuromuscular Diseases from a Historical Perspective to Current Prospects of Treatment.
Journal article
Gait MJ. et al, (2019), Nucleic Acid Ther, 29, 1 - 12
-
Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment.
Journal article
Betts CA. et al, (2019), Hum Mol Genet, 28, 396 - 406
-
Light modulation ameliorates expression of circadian genes and disease progression in spinal muscular atrophy mice.
Journal article
Walter LM. et al, (2018), Hum Mol Genet, 27, 3582 - 3597